Dr. Cole is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
Fairfax, VA 22031Phone+1 571-472-4724Fax+1 571-472-0241
Summary
- Dr. Marion Cole is an oncologist in Fairfax, VA and is affiliated with multiple hospitals in the area, including Inova Fairfax Hospital and Inova Children's Hospital. She received her medical degree from University of Maryland School of Medicine and has been in practice 10 years. She specializes in hematologic oncology.
Education & Training
- Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2007 - 2010
- University of Maryland School of MedicineClass of 2007
Certifications & Licensure
- VA State Medical License 2013 - 2024
- VA State Medical License 2013 - 2022
- PA State Medical License 2010 - 2014
- NJ State Medical License 2008 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 9 citationsBreast Cancer Treatment of Women with Schizophrenia and Bipolar Disorder from Philadelphia, PA: Lessons Learned and Suggestions for ImprovementMarion E. Cole, Aruna Padmanabhan
Journal of Cancer Education. 2012-07-18 - 17 citationsPeripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer.Marion E. Cole, Shobha Parajuli, Douglas W. Laske, Lori J. Goldstein, Tara Morrison
The American Journal of Case Reports. 2014-07-10 - 47 citationsNK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptorsAlexander W. MacFarlane, Mowafaq Jillab, Mitchell R. Smith, R. Katherine Alpaugh, Marion E. Cole
Oncoimmunology. 2017-05-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: